Hyperhidrosis in Patients With Amputations-Botox

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

January 15, 2022

Study Completion Date

February 14, 2022

Conditions
Hyperhidrosis
Interventions
DRUG

Botulinum Toxin Type A (Botox)

Maximum dose up to 400 units given one time

Trial Locations (2)

84132

University of Utah Hospital, Salt Lake City

84148

George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

collaborator

U.S. Army Medical Research and Development Command

FED

lead

University of Utah

OTHER

NCT03236012 - Hyperhidrosis in Patients With Amputations-Botox | Biotech Hunter | Biotech Hunter